|
|
|
|
LEADER |
06694nam a22005055i 4500 |
001 |
978-1-59745-293-9 |
003 |
DE-He213 |
005 |
20151204145145.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781597452939
|9 978-1-59745-293-9
|
024 |
7 |
|
|a 10.1007/978-1-59745-293-9
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC254-282
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Transforming Growth Factor-β in Cancer Therapy, Volume II
|h [electronic resource] :
|b Cancer Treatment and Therapy /
|c edited by Sonia B. Jakowlew.
|
264 |
|
1 |
|a Totowa, NJ :
|b Humana Press,
|c 2008.
|
300 |
|
|
|a XXVI, 786 p. 164 illus., 4 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Cancer Drug Discovery and Development
|
505 |
0 |
|
|a Transforming Growth Factor-? In Developing and Advanced Cancers -- Transforming Growth Factor-? Signaling in Pancreas Development and Pancreatic Disease -- Role of Transforming Growth Factor-? in the Pathogenesis of Human Head and Neck Squamous Cell Carcinoma -- TGF-?, Smads and Cervical Cancer -- TGF-? Signaling and Biglycan in Pancreatic Cancer -- TGF-? Signaling in Endometrial Cancer -- TGF-? Ligands, TGF-? Receptors, and Lung Cancer -- Role of TGF-? in Osteolytic Bone Metastases -- Hormonal Regulation of Transforming Growth Factor-? in Breast Cancer -- TGF-? and Progression of Esophageal Cancer -- TGF-? and HER2/ErbB2 and Breast Cancer Progression -- TGF-? Dependent T-Cell Regulation in Colitis and Colon Cancer -- Role of Transforming Growth Factor-? in the Kidney — Physiology and Pathology -- Perturbations of TGF-? Signaling in Leukocytes as Drivers of Leukemogenesis and Epithelial Tumorigenesis -- Transforming Growth Factor-? in Brain Functions and Dysfunctions -- Inhibition of TGF-? Signaling in Multiple Myeloma and Its Bone Marrow Microenvironment -- Key Roles of TGF-? and Smad3 in Prostate Cancer -- Smad Signaling in Leukemic Growth and Differentiation: Crosstalk Between Smad and Multiple Pathways Through Activation of the TGF-? Type I Receptor -- Transforming Growth Factor-? in Cancer Treatment and Therapy -- High-Throughput Screening of Protein Interaction Networks in the TGF? Interactome: Understanding the Signaling Mechanisms Driving Tumor Progression -- Tumor Suppressor and Pro-progression Roles for TGF-? in Breast Cancer -- Tumor Suppressors p53 and TGF? Converge to Regulate the Alpha-Fetoprotein Oncodevelopmental Tumor Marker -- TGF?: Roles in DNA Damage Responses -- The Rationale for and Effects of Targeting TGF-? for Glioma Therapy -- Tumor Suppressor Functions of TGF?1 in T Cells -- Therapeutic Effects of Adenovirus-Mediated Gene Transfer of TGF-? Signal Antagonists on Undesirable Epithelial-Mesenchymal Transition and Neovascularization -- Role of TGF-? in Tumor Protection and Antitumor Immunity -- Regulation of Angiogenesis and Tumor Growth by Thrombospondin-1 -- Cancer-Associated Fibroblasts and the Role of TGF-? -- Adoptive Transfer of Tumor Reactive TGF-? Insensitive CD8+ T-cells for Cancer Therapy -- DNA Methylation and Histone Deacetylation Inhibitors as Potential Therapeutic Agents for the Reconstitution of TGF-? Signaling in Breast Cancer -- Reactive Stroma and Evolution of Tumors: Integration of Transforming Growth Factor-?, Connective Tissue Growth Factor, and Fibroblast Growth Factor-2 Activities -- TGF-? Signaling and Vascular Morphogenesis -- Aberrant Transforming Growth Factor-? Signaling in Human Pancreatic Cancer: Translational Implications -- TGF-? and Stromal Influences Over Local Tumor Invasion -- TGF-? at the Crossroads Between Inflammation, Suppression and Cancer -- Development of Inhibitors of Transforming Growth Factor-? Signaling for Therapy -- Transforming Growth Factor-? (TGF-?) Signaling Inhibitors in Cancer Therapy -- Targeting TGF-? as a Strategy to Ameliorate Intestinal Side Effects of Radiation Therapy -- Targeting Transforming Growth Factor-? in Metastasis: In Vitro and In Vivo Mechanisms -- Targeted Downregulation of TGF-?2 with AP 12009 in Tumor Therapy -- Modulating TGF-? Receptor Signaling: A Novel Approach of Cancer Therapy -- Engineering TGF-? Traps: Artificially Dimerized Receptor Ectodomains as High-affinity Blockers of TGF-? Action -- The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology -- Soluble Type II Transforming Growth Factor-? Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity -- Reversal of EMT by Small-Molecule Inhibitors of TGF-? Type I and II Receptors: Implications for Carcinoma Treatment -- Soluble TGF-? Type III Receptor Suppresses Malignant Progression of Human Cancer Cells -- Targeting Smad-Dependent TGF-? Signaling with Peptide Aptamers -- Rationale for Anti-TGF-? Antibody Therapy in Oncology.
|
520 |
|
|
|a Transforming Growth Factor-ß in Cancer Therapy, Volumes 1 and 2, provides a compendium of findings about the role of transforming growth factor-ß (TGF-ß) in cancer treatment and therapy. The second volume, Cancer Treatment and Therapy, is divided into three parts. Part I examines transforming growth factor-ß in developing and advanced cancers. Part II details transforming growth factor-ß in cancer treatment and therapy. Part III includes an investigation into the development of inhibitors of transforming growth factor-ß signaling for therapy. This volume’s companion, Basic and Clinical Biology, examines transforming growth factor-ß signaling in normal physiology, cancer pathobiology, normal and tumor biology, and inflammation and fibrosis. Together, Transforming Growth Factor-ß in Cancer Therapy, Volumes 1 and 2, provide researchers and clinicians with a comprehensive and cutting-edge reference for the findings about the role of transforming growth factor-ß in biology and cancer treatment.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Oncology.
|
650 |
|
0 |
|a Pathology.
|
650 |
|
0 |
|a Cell biology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Cell Biology.
|
650 |
2 |
4 |
|a Pathology.
|
700 |
1 |
|
|a Jakowlew, Sonia B.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781588297150
|
830 |
|
0 |
|a Cancer Drug Discovery and Development
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-59745-293-9
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|